Paper

A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study

Multiple Sclerosis and Related Disorders · 2018 · Julian Gold, Monica Marta, Ute C Meier et al.